Lancet Neurology
A new hope for patients with non-dystrophic myotonia
Mexiletine, a sodium channel blocker, was effective in treating non-dystrophic myotonia, making it the standard treatment.
Mexiletine, a sodium channel blocker, was effective in treating non-dystrophic myotonia, making it the standard treatment.